FDA 510(k)
FDA class 1
Substantially Equivalent
🇫🇷 France
VIDAS C DIFFICILE GDH
K Number: K132010
·
Decision Oct 9, 2013
Classifications
1
FEI Numbers
8
Registration Numbers
8
Same Product Code
9
Applicant Total
16
Review Days
100
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- VIDAS C DIFFICILE GDH
- K Number
- K132010
- Device Class
- FDA class 1
- Clearance Type
- Traditional
- Regulation Number
- 866.2660
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Biomerieux S.A.
- Date Received
- July 1, 2013
- Decision Date
- October 9, 2013
- Product Code
- MCB
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MCB | Antigen, C. Difficile | FDA class 1 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (MCB), ordered by most recent decision date.
IMMUNOCARD C. DIFFICILE GDH
FDA 510(k)
FDA Class 1
·Microbiology
PREMIER C. DIFFICILE GDH
FDA 510(k)
FDA Class 1
·Microbiology
C. DIFF QUIK CHEK
FDA 510(k)
FDA Class 1
·Microbiology
TRIAGE C. DIFFICILE, TRIAGE C. DIFFICILE PANEL, TRIAGE C. DIFFICILE TOXIN A
FDA 510(k)
FDA Class 1
·Microbiology
CLEARVIEW C. DIFF A
FDA 510(k)
FDA Class 1
·Microbiology
MERITEC C. DIFFICILE CONTROLS
FDA 510(k)
FDA Class 1
·Microbiology
Other Clearances by Biomerieux S.A.
| K Number | Device Name | ||
|---|---|---|---|
| K250274 | ETEST Imipenem/Relebactam P. aeruginosa (IRPA) (0.008/4-128/4 µg/mL) | Apr 30, 2025 | Substantially Equivalent |
| K210757 | ETEST Fosfomycin (FO) (0.032-512 µg/mL) | Nov 12, 2021 | Substantially Equivalent |
| K192738 | ETEST Delafloxacin (DFX) (0.002-32 µg/mL) | Nov 26, 2019 | Substantially Equivalent |
| K192050 | ETEST Eravacycline (ERV) (0.002 32 µg/mL) | Sep 27, 2019 | Substantially Equivalent |
| K191953 | ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL) | Aug 22, 2019 | Substantially Equivalent |
| K190154 | ETEST Piperacillin/Tazobactam (P/T) (0.016/4-256/4 ug/mL) | May 1, 2019 | Substantially Equivalent |
| K183031 | ETEST Meropenem/Vaborbactam (MEV) (0.004/8-64/8 µg/mL) | Jan 11, 2019 | Substantially Equivalent |
| K181092 | CHROMID CARBA agar (CARB) | Jul 6, 2018 | Substantially Equivalent |
| K180936 | ETEST Telavancin (TLA) (0.002-32 ug/mL) | Jul 3, 2018 | Substantially Equivalent |
| K162385 | RAPIDEC CARBA NP | Apr 27, 2017 | Substantially Equivalent |